Leavell Investment Management’s AbbVie ABBV Stock Holding History

Leavell Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$18.9M	Sell	74,935 -89	-0.1%	-$19.1K	0.69%	26
2026 Q1	$16.3M	Sell	75,024 -1,191	-2%	-$264K	0.67%	28
2025 Q4	$17.4M	Hold	76,215	–	–	0.72%	27
2025 Q3	$17.6M	Sell	76,215 -3,208	-4%	-$653K	0.74%	29
2025 Q2	$14.7M	Sell	79,423 -438	-0.5%	-$81.4K	0.66%	32
2025 Q1	$16.7M	Buy	79,861 +187	+0.2%	+$36.4K	0.83%	29
2024 Q4	$14.2M	Buy	79,674 +629	+0.8%	+$116K	0.69%	32
2024 Q3	$15.6M	Buy	79,045 +8,076	+11%	+$1.51M	0.78%	29
2024 Q2	$12.2M	Sell	70,969 -717	-1%	-$119K	0.67%	31
2024 Q1	$13.1M	Buy	71,686 +453	+0.6%	+$78.1K	0.75%	28
2023 Q4	$11M	Buy	71,233 +38	+0.1%	+$5.54K	0.7%	34
2023 Q3	$10.6M	Sell	71,195 -1,280	-2%	-$188K	0.74%	33
2023 Q2	$9.77M	Sell	72,475 -1,229	-2%	-$180K	0.66%	41
2023 Q1	$11.7M	Sell	73,704 -2,583	-3%	-$395K	0.84%	30
2022 Q4	$12.3M	Sell	76,287 -1,857	-2%	-$285K	0.93%	26
2022 Q3	$10.5M	Buy	78,144 +927	+1%	+$133K	0.83%	29
2022 Q2	$11.8M	Buy	77,217 +555	+0.7%	+$84.8K	0.91%	23
2022 Q1	$12.4M	Sell	76,662 -1,728	-2%	-$251K	0.85%	25
2021 Q4	$10.6M	Sell	78,390 -1,628	-2%	-$192K	0.71%	38
2021 Q3	$8.63M	Buy	80,018 +9,679	+14%	+$1.11M	0.64%	46
2021 Q2	$7.61M	Hold	70,339	–	–	0.62%	48
2021 Q1	$7.61M	Buy	70,339 +1,568	+2%	+$168K	0.62%	48
2020 Q4	$7.37M	Sell	68,771 -207	-0.3%	-$19.9K	0.64%	46
2020 Q3	$6.04M	Sell	68,978 -134	-0.2%	-$12.6K	0.53%	57
2020 Q2	$6.79M	Buy	69,112 +1,296	+2%	+$114K	0.66%	45
2020 Q1	$5.17M	Sell	67,816 -841	-1%	-$71.6K	0.6%	53
2019 Q4	$6.08M	Buy	68,657 +575	+0.8%	+$47.7K	0.57%	45
2019 Q3	$5.16M	Sell	68,082 -226	-0.3%	-$15.5K	0.53%	54
2019 Q2	$4.97M	Sell	68,308 -986	-1%	-$77.5K	0.52%	55
2019 Q1	$5.58M	Buy	69,294 +123	+0.2%	+$10.1K	0.62%	43
2018 Q4	$6.38M	Sell	69,171 -868	-1%	-$76.3K	0.8%	30
2018 Q3	$6.62M	Buy	70,039 +1,300	+2%	+$123K	0.71%	32
2018 Q2	$6.37M	Buy	68,739 +1,283	+2%	+$125K	0.72%	30
2018 Q1	$6.38M	Sell	67,456 -350	-0.5%	-$38.4K	0.74%	28
2017 Q4	$6.56M	Sell	67,806 -400	-0.6%	-$37.7K	0.77%	31
2017 Q3	$6.06M	Hold	68,206	–	–	0.75%	35
2017 Q2	$4.95M	Sell	68,206 -625	-0.9%	-$42K	0.63%	44
2017 Q1	$4.49M	Buy	68,831 +630	+0.9%	+$39.6K	0.58%	50
2016 Q4	$4.27M	Buy	68,201 +254	+0.4%	+$15.5K	0.59%	46
2016 Q3	$4.29M	Buy	67,947 +1,161	+2%	+$75.2K	0.63%	42
2016 Q2	$4.13M	Buy	66,786 +245	+0.4%	+$14.9K	0.61%	43
2016 Q1	$3.8M	Buy	66,541 +360	+0.5%	+$20.1K	0.57%	46
2015 Q4	$3.92M	Buy	66,181 +4,398	+7%	+$253K	0.57%	40
2015 Q3	$3.36M	Buy	61,783 +2,808	+5%	+$183K	0.53%	46
2015 Q2	$3.96M	Sell	58,975 -670	-1%	-$43.7K	0.62%	35
2015 Q1	$3.49M	Buy	59,645 +2,800	+5%	+$169K	0.53%	46
2014 Q4	$3.72M	Buy	56,845 +470	+0.8%	+$29.6K	0.57%	39
2014 Q3	$3.26M	Hold	56,375	–	–	0.52%	54
2014 Q2	$3.18M	Buy	56,375 +1,685	+3%	+$88.4K	0.5%	55
2014 Q1	$2.81M	Buy	54,690 +2,500	+5%	+$126K	0.47%	63
2013 Q4	$2.76M	Buy	52,190 +1,900	+4%	+$93.4K	0.47%	63
2013 Q3	$2.25M	Buy	50,290 +16,000	+47%	+$709K	0.4%	74
2013 Q2	$1.42M	Buy	+34,290	New	+$1.5M	0.26%	106

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Leavell Investment Management's ABBV Position: Q2 2026 in Review

Leavell Investment Management reduced its AbbVie (ABBV) stake by 0.12% in Q2 2026, selling an estimated $19.1K and leaving 74,935 shares worth $18.9M. The position accounts for 0.69% of the portfolio, ranked #26.

Leavell Investment Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 4,189 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Leavell Investment Management held 74,935 shares of AbbVie worth $18.9M as of Q2 2026.
Leavell Investment Management sold 89 AbbVie shares in Q2 2026, an estimated $19.1K.
AbbVie made up 0.69% of Leavell Investment Management's portfolio in Q2 2026, its #26 holding.
Leavell Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
4,189 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Leavell Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.